Improvements in Mucopolysaccharidosis I Mice After Adult Retroviral Vector–mediated Gene Therapy with Immunomodulation

This publication has 41 references indexed in Scilit:

• Gene therapy for lysosomal storage diseases
  Molecular Therapy, 2006
• Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice
  Molecular Therapy, 2005
• Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human α-l-iduronidase gene
  Molecular Therapy, 2004
• Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome
  New England Journal of Medicine, 2004
• Enzyme replacement and enhancement therapies for lysosomal diseases
  Journal of Inherited Metabolic Disease, 2004
• Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow
  Molecular Genetics and Metabolism, 2003
• Enzyme Replacement Therapy in Feline Mucopolysaccharidosis I
  Molecular Genetics and Metabolism, 2001
• Enzyme-Replacement Therapy in Mucopolysaccharidosis I
  New England Journal of Medicine, 2001
• Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis I
  Biochemical and Molecular Medicine, 1996
• An update on the frequency of mucopolysaccharide syndromes in British Columbia
  Human Genetics, 1990